Continuum Advisory, LLC

SEC CIK: 0001846532
Latest filing: Aug 6, 2026

SEC filings (opens in a new tab)

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Continuum Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overview All 13F holders of ALNY Full Q2 2026 holdings

Shares (Q2 2026): 38
Value: $11.4K
% of portfolio: <0.1%
Quarters held: 3; Since Q3 2024

Holdings of ALNY by Continuum Advisory, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	38	$11.4K	<0.1%	+38	New	Holders
Q1 2025	0	$0	0.0%	−6−100.0%	Sold out	Holders
Q4 2024	6	$1.41K	<0.1%	00.0%	Unchanged	Holders
Q3 2024	6	$1.55K	<0.1%	+6	New	Holders